Skip to main content

Table 4 Factors associated with anticoagulant therapy in all patients and those with high risk of stroke (Multivariate logistic regression)

From: Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study

 All patientspatients with high risk of stroke
VariablesBOR (95% CI)P valueBOR (95% CI)P value
Gender, Female0.2101.234 (0.848~1.796)0.2720.0431.044 (0.681~1.601)0.844
Payment, Self-paying0.6011.824 (1.136~2.928)0.0130.8842.234 (1.167~4.277)0.015
Age (per 1 year increase)0.0291.030 (1.010~1.050)0.0030.0531.055 (1.028~1.082)< 0.001
Education−0.1800.835 (0.553~1.260)0.391−0.0600.941 (0.565~1.568)0.817
AF type, Permanent−0.9020.406 (0.206~0.800)0.009−0.6150.541 (0.253~1.157)0.113
Duration, ≥5 years0.4091.505 (1.035~2.189)0.0330.2861.332 (0.863~2.055)0.196
Severity of symptom−0.0030.997 (0.774~1.283)0.9790.0571.059 (0.598~1.874)0.845
HAS-BLED, score ≥ 3−0.3160.729 (0.384~1.385)0.334−0.1960.822 (0.446~1.516)0.530
CHA2DS2-VASC, (per 1score increase)−0.1170.890 (0.747~1.059)0.190−0.0580.944 (0.736~1.210)0.647
Hypertension   0.4561.578 (0.966~2.578)0.068
  1. Abbreviations: AF Atrial fibrillation, CHA2DS2-VASc Congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65–74 years, sex category (female), CI Confidence interval, HAS-BLED Hypertension, abnormal renal and/or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly (age > 65 years), drugs and/or alcohol concomitantly, OR Odds ratio